HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Akira Hashiramoto Selected Research
Akira Hashiramoto Research Topics
Disease
22
Rheumatoid Arthritis
08/2021 - 01/2005
4
Arthritis (Polyarthritis)
07/2020 - 08/2002
2
Autoimmune Diseases (Autoimmune Disease)
03/2020 - 07/2013
2
Glomerulonephritis
01/2019 - 07/2013
2
Infections
08/2012 - 07/2011
2
Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2011 - 09/2004
2
Osteoporosis
05/2005 - 04/2005
1
Churg-Strauss Syndrome (Allergic Angiitis)
01/2021
1
Vasculitis (Vasculitides)
01/2021
1
Thromboinflammation
01/2021
1
Experimental Arthritis
07/2020
1
Alopecia (Baldness)
01/2019
1
Leukemia
01/2018
1
Rheumatic Diseases (Rheumatism)
06/2017
1
Hypergammaglobulinemia (Hyperimmunoglobulinemia)
01/2009
1
Disease Susceptibility (Diathesis)
08/2008
1
Osteoarthritis
03/2006
1
Ascites
09/2004
1
Central Nervous System Lupus Vasculitis
09/2004
1
Peritonitis
09/2004
1
Psychotic Disorders (Schizoaffective Disorder)
09/2004
1
Type 2 Diabetes Mellitus (MODY)
03/2003
1
Insulin Resistance
03/2003
1
Osteopetrosis
06/2002
Drug/Important Bio-Agent (IBA)
6
Cytokines
IBA
07/2020 - 07/2008
5
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2018 - 07/2008
4
Methotrexate (Mexate)
FDA Link
Generic
01/2018 - 01/2005
3
Cell-Free Nucleic Acids
IBA
08/2021 - 06/2017
2
Ligands
IBA
07/2020 - 05/2005
2
Osteoprotegerin
IBA
07/2020 - 05/2005
2
Autoantibodies
IBA
01/2019 - 07/2013
2
Antigen-Antibody Complex (Immune Complex)
IBA
01/2019 - 07/2013
2
Member 25 Tumor Necrosis Factor Receptors
IBA
01/2018 - 03/2006
2
Biological Products
IBA
06/2017 - 11/2012
2
tocilizumab (atlizumab)
FDA Link
11/2013 - 11/2012
2
Pharmaceutical Preparations
IBA
11/2012 - 01/2005
2
Tumor Necrosis Factor Inhibitors
IBA
08/2012 - 07/2011
2
Antirheumatic Agents (DMARD)
IBA
06/2012 - 07/2011
2
Transcription Factor AP-1 (Transcription Factor AP 1)
IBA
07/2008 - 04/2005
2
DNA (Deoxyribonucleic Acid)
IBA
03/2006 - 04/2005
1
Antineutrophil Cytoplasmic Antibodies (ANCA)
IBA
01/2021
1
Deoxyribonucleases (DNase)
FDA Link
01/2021
1
Albumins
IBA
01/2018
1
Carrier Proteins (Binding Protein)
IBA
01/2018
1
Messenger RNA (mRNA)
IBA
01/2018
1
Etanercept (Enbrel)
FDA Link
11/2012
1
Infliximab (Remicade)
FDA Link
11/2012
1
Adalimumab (Humira)
FDA Link
06/2012
1
Peptides (Polypeptides)
IBA
10/2011
1
Alanine (L-Alanine)
FDA Link
10/2011
1
mica
IBA
10/2011
1
Cryptochromes
IBA
02/2010
1
Phosphotransferases (Kinase)
IBA
02/2010
1
Interleukin-6 (Interleukin 6)
IBA
02/2010
1
cevimeline (Evoxac)
FDA Link
01/2009
1
Collagen Type II (Type II Collagen)
IBA
07/2008
1
Interleukin-1beta (Interleukin 1 beta)
IBA
07/2008
1
Matrix Metalloproteinases (MMPs)
IBA
07/2008
1
C-Reactive Protein
IBA
03/2008
1
cyclic citrullinated peptide
IBA
03/2008
1
Rheumatoid Factor
IBA
03/2008
1
Angiopoietin-1
IBA
07/2007
1
Proteins (Proteins, Gene)
FDA Link
03/2006
1
Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)
IBA
05/2005
1
Estrogens (Estrogen)
FDA Link
05/2005
1
Heat-Shock Proteins (Heat-Shock Protein)
IBA
04/2005
1
Capsules (Microcapsules)
IBA
01/2005
1
Methylprednisolone
FDA Link
Generic
09/2004
1
Steroids
IBA
09/2004
1
Diuretics
IBA
09/2004
1
G(M3) Ganglioside
IBA
03/2003
1
Insulin Receptor
IBA
03/2003
1
Insulin (Novolin)
FDA Link
03/2003
1
pristane (pristan)
IBA
08/2002
1
Macrophage Colony-Stimulating Factor
IBA
06/2002
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
06/2002
Therapy/Procedure
5
Therapeutics
11/2013 - 09/2004
1
Chronotherapy
07/2020
1
Biological Therapy
11/2012